http://www.esperion.com
Esperion Therapeutics, Inc. Company Intro
ESPERION is The Lipid Management Company, pursuing the research and development of novel lipid-lowering therapies for everybody.
Industry
Healthcare
Esperion Therapeutics, Inc. Headquaters
3891 Ranchero Drive
Ann Arbor,48108
United States
Esperion Therapeutics, Inc. Share price
22 Jan 2021 01:35 GMT
$25.35
-0.05 (-0.2 %)
Esperion Therapeutics, Inc. Market cap
$658.559 M
WMC RANKING
2021
Esperion Therapeutics, Inc. # 48
BiotechnologyLatest Esperion Therapeutics, Inc. News
20 Jan 2021
Pandemic puts pressure on drug sales | 2021-01-19
Esperion Therapeutics Inc., for example, estimated its fourth quarter 2020 U.S. net product revenue landed between $8 million and $8.5 million. The Ann Arbor ...
20 Jan 2021
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Stock: A Game ...
In the last trading session, 1,213,212 shares of the Esperion Therapeutics, Inc.(NASDAQ:ESPR) were traded, and its beta was 1.31. Most recently the company's ...
20 Jan 2021
Esperion Therapeutics Inc. (ESPR) Soars 1.11% on January 20
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated ...
WMC Market Score
WMC Market to Revenue Score
Esperion Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Esperion Therapeutics, Inc. | USD | $148,364 | $241,465 | $-97,165 | $6,586M | 48 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Esperion Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Esperion Therapeutics, Inc. Post vs Top 4 Industry Competitors
Esperion Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Esperion Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Esperion Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Esperion Therapeutics, Inc. | 1.61 | 1.80 | 15.45 | 0 | 0 | 0 | 8.82 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
